BioRestorative Therapies receives patent allowance for TheroStem

BioRestorative Therapies (BRTX) announces that the Israel Patent Office has issued a Notice of Allowance for a new patent application covering several fundamental aspects of the Company’s allogeneic, off-the-shelf ThermoStem platform. This, the 14th international patent to issue outside of the U.S. for BioRestorative’s ThermoStem technology platform, covers non-naturally occurring three-dimensional brown adipose derived stem cell aggregates; an encapsulation system comprising the non-naturally occurring three-dimensional brown adipose derived stem cell aggregates; a method of making a non-naturally occurring three-dimensional brown adipose derived stem cell aggregate; and a method of treating a patient with a disorder.